Park S - Search Results

1

Clinical features of Waldenstrom macroglobulinemia in Korea.

Bang SM, Park SR, Park SH, Cho EK, Yoon SS, Shin DB, Lee JH, Park S, Kim BK, Kim NK. Bang SM, et al. Among authors: park sr, park s, park sh. Korean J Intern Med. 2004 Sep;19(3):137-40. doi: 10.3904/kjim.2004.19.3.137. Korean J Intern Med. 2004. PMID: 15481603 Free PMC article.

2

Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer.

Choi IS, Kim BS, Park SR, Lee SY, Kim DY, Kim JH, Lee SH, Kim TY, Heo DS, Bang YJ, Kim NK. Choi IS, et al. Lung Cancer. 2003 Jan;39(1):99-101. doi: 10.1016/s0169-5002(02)00389-6. Lung Cancer. 2003. PMID: 12499101 Clinical Trial.

3

Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.

Park SR, Kim JH, Kim DY, Lee S, Lee SY, Choi IS, Yoon SS, Park S, Kim BG, Kim NK. Park SR, et al. Among authors: park s. Korean J Intern Med. 2003 Mar;18(1):21-8. doi: 10.3904/kjim.2003.18.1.21. Korean J Intern Med. 2003. PMID: 12760264 Free PMC article.

4

Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.

Kim DY, Lee KW, Yun T, Park SR, Jung JY, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK. Kim DY, et al. Jpn J Clin Oncol. 2003 Dec;33(12):608-12. doi: 10.1093/jjco/hyg118. Jpn J Clin Oncol. 2003. PMID: 14769837

5

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

Park SR, Oh DY, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK, Kang WK, Kim HT, Im SA, Suh JH, Kim HK, Kim HK. Park SR, et al. Oncol Rep. 2004 Nov;12(5):1059-64. Oncol Rep. 2004. PMID: 15492793 Clinical Trial.

6

Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.

Choi IS, Oh DY, Kwon JH, Kim SI, Park SR, Bak JY, Kim JH, Kim DW, Kim YT, Kim TY, You CK, Kim YW, Heo DS, Bang YJ, Sung SW, Park CI, Kim NK. Choi IS, et al. Jpn J Clin Oncol. 2005 Jan;35(1):6-12. doi: 10.1093/jjco/hyi008. Jpn J Clin Oncol. 2005. PMID: 15681597

7

Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.

Park SR, Baek JY, Kim DW, Im SA, Kim TY, Bang YJ, Kim NK, Jeon YK, Kim CW, Heo DS. Park SR, et al. J Korean Med Sci. 2006 Aug;21(4):633-8. doi: 10.3346/jkms.2006.21.4.633. J Korean Med Sci. 2006. PMID: 16891805 Free PMC article.

8

Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer.

Han HS, Park SR, Kim SY, Park YI, Lee JS, Kook MC, Choi IJ, Kim CG, Lee JR, Cho SJ, Kim NK. Han HS, et al. J Clin Oncol. 2008 Feb 20;26(6):1006-8. doi: 10.1200/JCO.2007.14.7231. J Clin Oncol. 2008. PMID: 18281674 No abstract available.

9

Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer.

Kong SY, Lim HS, Nam BH, Kook MC, Kim YW, Ryu KW, Lee JH, Choi IJ, Lee JS, Park YI, Kim NK, Park SR. Kong SY, et al. Pharmacogenomics. 2009 Jul;10(7):1147-55. doi: 10.2217/pgs.09.48. Pharmacogenomics. 2009. PMID: 19604090 Clinical Trial.

10

Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients.

Park SR, Kook MC, Choi IJ, Kim CG, Lee JY, Cho SJ, Kim YW, Ryu KW, Lee JH, Lee JS, Park YI, Kim NK. Park SR, et al. Cancer Chemother Pharmacol. 2010 Feb;65(3):579-87. doi: 10.1007/s00280-009-1067-9. Epub 2009 Jul 24. Cancer Chemother Pharmacol. 2010. PMID: 19629485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,258 results

Search Page

Filters